News
Ho deciso di andare al mare ma voglio sapere esattamente quanto "violento" sarà l'irraggiamento solare quel giorno. Basta un ...
Torna anche quest’anno "Amici per la Pelle 3.0", la giornata dedicata alla prevenzione dei tumori cutanei promossa da Adeca – ...
You’ve probably heard of the four stages of cancer—but there’s another even earlier stage that experts say can make a huge difference in treating the disease. Breast cancer is one of the few ...
29 NOV - Angosciante, subdolo e disgustoso. Sono questi gli aggettivi più utilizzati dagli italiani che hanno conosciuto il carcinoma basocellulare avanzato. Il carcinoma basocellulare o ...
for the first-line treatment of adults with recurrent or metastatic nonkeratinizing nasopharyngeal carcinoma (NPC); or as a single agent, for the treatment of adults with metastatic ...
Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced nasopharyngeal carcinoma. The FDA has approved Akeso’s penpulimab-kcqx, a ...
New data show early hints of the medicine improving patient survival — the gold standard outcome of any cancer study. The drug, ivonescimab, was approved for previously untreated patients with ...
I’ve spent recent weeks speaking with scientists and executives at universities, major companies, and research institutions—including Pfizer, Moderna, and the Memorial Sloan Kettering Cancer ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma. The United States Food and Drug Administration (FDA) has approved ...
Dana Schulz is an experienced editor, writer, and content strategist who is just as likely to be crunching the ... We offer the most up-to-date information from top experts, new research, and health ...
Marly Garnreiter / SWNS A woman put her symptoms into the artificial intelligence program ChatGPT but says she “ignored” the chatbot’s cancer diagnosis — until a year later when she was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results